Krystal Biotech, Inc. (KRYS)

277.23 +4.57 (+1.68%) USD  |  NASDAQ  |  Apr 22, 12:19
More

Krystal Biotech Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Scholar Rock Holding Corp. Upgrade
Stoke Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
TG Therapeutics, Inc. Upgrade